Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

Clinical trial NCT04925011 · UNKNOWN

Trial details

NCT number: NCT04925011
Sponsor: Mao Jianhua
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia Associated With Chronic Kidney Disease

Start date: 2021-09-01
Primary completion: 2022-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.